Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 812

1.

NIST Interlaboratory Study on Glycosylation Analysis of Monoclonal Antibodies: Comparison of Results from Diverse Analytical Methods.

De Leoz MLA, Duewer DL, Fung A, Liu L, Yau HK, Potter O, Staples GO, Furuki K, Frenkel R, Hu Y, Sosic Z, Zhang P, Altmann F, Gruber C, Shao C, Zaia J, Evers W, Pangelley S, Suckau D, Wiechmann A, Resemann A, Jabs W, Beck A, Froehlich JW, Huang C, Li Y, Liu Y, Sun S, Wang Y, Seo Y, An HJ, Reichardt NC, Ruiz JE, Archer-Hartmann S, Azadi P, Bell L, Lakos Z, An Y, Cipollo JF, Pučić-Baković M, Štambuk J, Lauc G, Li X, Wang PG, Bock A, Hennig R, Rapp E, Creskey M, Cyr T, Nakano M, Sugiyama T, Leung PA, Link-Lenczowski P, Jaworek J, Yang SJ, Zhang H, Kelly T, Klapoetke S, Cao R, Kim JY, Lee HK, Lee J, Yoo JS, Kim SR, Suh SK, de Haan N, Falck D, Lageveen-Kammeijer GSM, Wuhrer M, Emery RJ, Kozak RP, Liew LP, Royle L, Urbanowicz PA, Packer N, Song X, Everest-Dass A, Lattová E, Cajic S, Alagesan K, Kolarich D, Kasali T, Lindo V, Chen Y, Goswami K, Gau B, Amunugama R, Jones R, Stroop CJM, Kato K, Yagi H, Kondo S, Yuen CT, Harazono A, Shi X, Magnelli P, Kasper BT, Mahal LK, Harvey DJ, O'Flaherty RM, Rudd P, Saldova R, Hecht ES, Muddiman DC, Kang J, Bhoskar P, Menard D, Saati A, Merle C, Mast S, Tep S, Truong J, Nishikaze T, Sekiya S, Shafer A, Funaoka S, Toyoda M, de Vreugd P, Caron C, Pradhan P, Tan NC, Mechref Y, Patil S, Rohrer JS, Chakrabarti R, Dadke D, Lahori M, Zou C, Cairo CW, Reiz B, Whittal RM, Lebrilla C, Wu LD, Guttman A, Szigeti M, Kremkow BG, Lee K, Sihlbom C, Adamczyk B, Jin C, Karlsson NG, Örnros J, Larson G, Nilsson J, Meyer B, Wiegandt A, Komatsu E, Perreault H, Bodnar ED, Said N, Francois YN, Leize-Wagner E, Maier S, Zeck A, Heck AJR, Yang Y, Haselberg R, Yu YQ, Alley W, Leone JW, Yuan H, Stein SE.

Mol Cell Proteomics. 2019 Oct 7. pii: mcp.RA119.001677. doi: 10.1074/mcp.RA119.001677. [Epub ahead of print]

2.

Nivolumab-induced fulminant type 1 diabetes with precipitous fall in C-peptide level.

Miyauchi M, Toyoda M, Zhang J, Hamada N, Yamawaki T, Tanaka J, Harada K, Kashizaki F, Fukagawa M.

J Diabetes Investig. 2019 Oct 6. doi: 10.1111/jdi.13143. [Epub ahead of print]

3.

Caution is required for the evaluation of the accuracy of continuous glucose monitoring devices.

Hirota Y, Toyoda M, Murata T, Miura J.

J Diabetes Investig. 2019 Oct 1. doi: 10.1111/jdi.13149. [Epub ahead of print] No abstract available.

4.

Frequent retrotransposition of endogenous genes in ERCC2-deficient cells derived from a patient with xeroderma pigmentosum.

Aoto S, Katagiri S, Wang Y, Pagnamenta AT, Sakamoto-Abutani R, Toyoda M, Umezawa A, Okamura K.

Stem Cell Res Ther. 2019 Aug 27;10(1):273. doi: 10.1186/s13287-019-1381-z.

5.

On Optimal Time-Varying Feedback Controllability for Probabilistic Boolean Control Networks.

Toyoda M, Wu Y.

IEEE Trans Neural Netw Learn Syst. 2019 Aug 1. doi: 10.1109/TNNLS.2019.2927241. [Epub ahead of print]

PMID:
31395555
6.

Modelling and in vitro testing of the HIV-1 Nef fitness landscape.

Barton JP, Rajkoomar E, Mann JK, Murakowski DK, Toyoda M, Mahiti M, Mwimanzi P, Ueno T, Chakraborty AK, Ndung'u T.

Virus Evol. 2019 Aug 5;5(2):vez029. doi: 10.1093/ve/vez029. eCollection 2019 Jul.

7.

Impact of Tocilizumab (Anti-IL-6R) Treatment on Immunoglobulins and Anti-HLA Antibodies in Kidney Transplant Patients with Chronic Antibody-Mediated Rejection.

Shin BH, Everly MJ, Zhang H, Choi J, Vo A, Zhang X, Huang E, Jordan SC, Toyoda M.

Transplantation. 2019 Aug 1. doi: 10.1097/TP.0000000000002895. [Epub ahead of print]

PMID:
31385933
8.
9.

Enhanced morphological and functional differences of pancreatic cancer with epithelial or mesenchymal characteristics in 3D culture.

Shichi Y, Sasaki N, Michishita M, Hasegawa F, Matsuda Y, Arai T, Gomi F, Aida J, Takubo K, Toyoda M, Yoshimura H, Takahashi K, Ishiwata T.

Sci Rep. 2019 Jul 26;9(1):10871. doi: 10.1038/s41598-019-47416-w.

10.

Prediction model of compensation for contralateral kidney after living-donor donation.

Okumura K, Yamanaga S, Tanaka K, Kinoshita K, Kaba A, Fujii M, Ogata M, Hidaka Y, Toyoda M, Uekihara S, Miyata A, Inadome A, Yokomizo H.

BMC Nephrol. 2019 Jul 26;20(1):283. doi: 10.1186/s12882-019-1464-1.

11.

The Effect of High-concentration Insulin Glarigine on the Quality of Life of Patients with Type 2 Diabetes Mellitus: A Pre-post Study (HIGH-QOL STUDY).

Murata T, Tone A, Kouyama R, Kamiuchi K, Narasaki K, Tsuruo M, Watanabe T, Kawashima S, Kato K, Sawaki H, Osawa K, Kimura M, Toyoda M, Suganuma A, Sakane N; HIGH-QOL study group.

Intern Med. 2019 Oct 15;58(20):2943-2948. doi: 10.2169/internalmedicine.1794-18. Epub 2019 Jun 27.

12.

The C-terminal flexible region of branched-chain polyamine synthase facilitates substrate specificity and catalysis.

Hidese R, Toyoda M, Yoshino KI, Fukuda W, Wihardja GA, Kimura S, Fujita J, Niitsu M, Oshima T, Imanaka T, Mizohata E, Fujiwara S.

FEBS J. 2019 Oct;286(19):3926-3940. doi: 10.1111/febs.14949. Epub 2019 Jun 21.

PMID:
31162806
13.

Effect of Serum Parathyroid Hormone on Tacrolimus Therapy in Kidney Transplant Patients: A Possible Biomarker for a Tacrolimus Dosage Schedule.

Hirata K, Watanabe H, Toyoda M, Sugimoto R, Ikegami K, Imafuku T, Matsuzaka K, Ichimizu S, Maeda H, Uekihara S, Jingami S, Maruyama T.

Biol Pharm Bull. 2019;42(5):786-791. doi: 10.1248/bpb.b18-00976.

14.

Prior cycling exercise does not prevent endothelial dysfunction after resistance exercise.

Morishima T, Toyoda M, Ochi E.

Eur J Appl Physiol. 2019 Jul;119(7):1663-1669. doi: 10.1007/s00421-019-04154-1. Epub 2019 May 4.

PMID:
31055679
15.

Fetal bovine serum enlarges the size of human pancreatic cancer spheres accompanied by an increase in the expression of cancer stem cell markers.

Sasaki N, Toyoda M, Hasegawa F, Fujiwara M, Gomi F, Ishiwata T.

Biochem Biophys Res Commun. 2019 Jun 18;514(1):112-117. doi: 10.1016/j.bbrc.2019.04.117. Epub 2019 Apr 23.

PMID:
31027735
16.

Chronic Renal Failure as a Possible Risk Factor for Allergic Reaction in Therapeutic Plasma Exchange Using Fresh Frozen Plasma.

Eguchi M, Okumura K, Torigoe K, Toyoda M, Uekihara S, Yamanaga S.

Ther Apher Dial. 2019 Jun;23(3):261-265. doi: 10.1111/1744-9987.12823. Epub 2019 May 26.

PMID:
31026119
17.

Comparison of functional glycans between cancer stem cells and normal stem cells.

Sasaki N, Itakura Y, Gomi F, Hirano K, Toyoda M, Ishiwata T.

Histol Histopathol. 2019 Sep;34(9):995-1007. doi: 10.14670/HH-18-119. Epub 2019 Apr 26. Review.

PMID:
31025698
18.

Gangliosides Contribute to Vascular Insulin Resistance.

Sasaki N, Itakura Y, Toyoda M.

Int J Mol Sci. 2019 Apr 12;20(8). pii: E1819. doi: 10.3390/ijms20081819. Review.

19.

Exploratory analysis of prognostic factors for lenvatinib in radioiodine-refractory differentiated thyroid cancer.

Suzuki C, Kiyota N, Imamura Y, Goto H, Suto H, Chayahara N, Toyoda M, Ito Y, Miya A, Miyauchi A, Otsuki N, Nibu KI, Minami H.

Head Neck. 2019 Sep;41(9):3023-3032. doi: 10.1002/hed.25784. Epub 2019 Apr 23.

PMID:
31013380
20.

Effect of Sodium Glucose Co-Transporter 2 Inhibitors on Liver Fat Mass and Body Composition in Patients with Nonalcoholic Fatty Liver Disease and Type 2 Diabetes Mellitus.

Arase Y, Shiraishi K, Anzai K, Sato H, Teramura E, Tsuruya K, Hirose S, Deguchi R, Toyoda M, Mine T, Kagawa T.

Clin Drug Investig. 2019 Jul;39(7):631-641. doi: 10.1007/s40261-019-00785-6.

21.

A practical method of liberating O-linked glycans from glycoproteins using hydroxylamine and an organic superbase.

Kameyama A, Thet Tin WW, Toyoda M, Sakaguchi M.

Biochem Biophys Res Commun. 2019 May 21;513(1):186-192. doi: 10.1016/j.bbrc.2019.03.144. Epub 2019 Apr 2.

22.

N-Acetyl-seryl-aspartyl-lysyl-proline is a potential biomarker of renal function in normoalbuminuric diabetic patients with eGFR ≥ 30 ml/min/1.73 m2.

Nitta K, Nagai T, Mizunuma Y, Kitada M, Nakagawa A, Sakurai M, Toyoda M, Haneda M, Kanasaki K, Koya D.

Clin Exp Nephrol. 2019 Aug;23(8):1004-1012. doi: 10.1007/s10157-019-01733-6. Epub 2019 Apr 4.

PMID:
30949886
23.

A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy.

Kimura M, Toyoda M, Saito N, Kaneyama N, Miyatake H, Tanaka E, Komaba H, Hara M, Fukagawa M.

J Diabetes Res. 2019 Feb 17;2019:9475637. doi: 10.1155/2019/9475637. eCollection 2019.

24.

Adapalene Gel 0.1% Versus Placebo as Prophylaxis for Anti-Epidermal Growth Factor Receptor-Induced Acne-Like Rash: A Randomized Left-Right Comparative Evaluation (APPEARANCE).

Chayahara N, Mukohara T, Tachihara M, Fujishima Y, Fukunaga A, Washio K, Yamamoto M, Nakata K, Kobayashi K, Takenaka K, Toyoda M, Kiyota N, Tobimatsu K, Doi H, Mizuta N, Marugami N, Kawaguchi A, Nishigori C, Nishimura Y, Minami H.

Oncologist. 2019 Jul;24(7):885-e413. doi: 10.1634/theoncologist.2019-0156. Epub 2019 Mar 19.

25.

Metal Ions in Activated Carbon Improve the Detection Efficiency of Aflatoxin-Producing Fungi.

Suzuki T, Toyoda M.

Toxins (Basel). 2019 Mar 2;11(3). pii: E140. doi: 10.3390/toxins11030140.

26.

Quantification of hemodynamic irregularity using oscillatory velocity index in the associations with the rupture status of cerebral aneurysms.

Tanioka S, Ishida F, Kishimoto T, Tsuji M, Tanaka K, Shimosaka S, Toyoda M, Kashiwagi N, Sano T, Suzuki H.

J Neurointerv Surg. 2019 Jun;11(6):614-617. doi: 10.1136/neurintsurg-2018-014489. Epub 2019 Jan 22.

PMID:
30670624
27.

Randomized Phase II Trial Comparing Site-Specific Treatment Based on Gene Expression Profiling With Carboplatin and Paclitaxel for Patients With Cancer of Unknown Primary Site.

Hayashi H, Kurata T, Takiguchi Y, Arai M, Takeda K, Akiyoshi K, Matsumoto K, Onoe T, Mukai H, Matsubara N, Minami H, Toyoda M, Onozawa Y, Ono A, Fujita Y, Sakai K, Koh Y, Takeuchi A, Ohashi Y, Nishio K, Nakagawa K.

J Clin Oncol. 2019 Mar 1;37(7):570-579. doi: 10.1200/JCO.18.00771. Epub 2019 Jan 17.

PMID:
30653423
28.

A variant within the FTO confers susceptibility to diabetic nephropathy in Japanese patients with type 2 diabetes.

Taira M, Imamura M, Takahashi A, Kamatani Y, Yamauchi T, Araki SI, Tanaka N, van Zuydam NR, Ahlqvist E, Toyoda M, Umezono T, Kawai K, Imanishi M, Watada H, Suzuki D, Maegawa H, Babazono T, Kaku K, Kawamori R; SUMMIT Consortium, Groop LC, McCarthy MI, Kadowaki T, Maeda S.

PLoS One. 2018 Dec 19;13(12):e0208654. doi: 10.1371/journal.pone.0208654. eCollection 2018.

29.

Epigenetic-scale comparison of human iPSCs generated by retrovirus, Sendai virus or episomal vectors.

Nishino K, Arai Y, Takasawa K, Toyoda M, Yamazaki-Inoue M, Sugawara T, Akutsu H, Nishimura K, Ohtaka M, Nakanishi M, Umezawa A.

Regen Ther. 2018 Sep 1;9:71-78. doi: 10.1016/j.reth.2018.08.002. eCollection 2018 Dec.

30.

Thrombotic Microangiopathy with Severe Proteinuria Induced by Lenvatinib for Radioactive Iodine-Refractory Papillary Thyroid Carcinoma.

Hyogo Y, Kiyota N, Otsuki N, Goto S, Imamura Y, Chayahara N, Toyoda M, Nibu KI, Hyodo T, Hara S, Masuoka H, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.

Case Rep Oncol. 2018 Nov 12;11(3):735-741. doi: 10.1159/000494080. eCollection 2018 Sep-Dec.

31.

A phase I study of single-agent BEZ235 special delivery system sachet in Japanese patients with advanced solid tumors.

Toyoda M, Watanabe K, Amagasaki T, Natsume K, Takeuchi H, Quadt C, Shirao K, Minami H.

Cancer Chemother Pharmacol. 2019 Feb;83(2):289-299. doi: 10.1007/s00280-018-3725-2. Epub 2018 Nov 16.

32.

H19 long non-coding RNA contributes to sphere formation and invasion through regulation of CD24 and integrin expression in pancreatic cancer cells.

Sasaki N, Toyoda M, Yoshimura H, Matsuda Y, Arai T, Takubo K, Aida J, Ishiwata T.

Oncotarget. 2018 Oct 5;9(78):34719-34734. doi: 10.18632/oncotarget.26176. eCollection 2018 Oct 5.

33.

Bone marrow-derived mesenchymal stem cells inhibit vascular smooth muscle cell proliferation and neointimal hyperplasia after arterial injury in rats.

Iso Y, Usui S, Toyoda M, Spees JL, Umezawa A, Suzuki H.

Biochem Biophys Rep. 2018 Oct 24;16:79-87. doi: 10.1016/j.bbrep.2018.10.001. eCollection 2018 Dec.

34.

Renal effects of sodium glucose co-transporter 2 inhibitors in Japanese type 2 diabetes mellitus patients with home blood pressure monitoring.

Kobayashi K, Toyoda M, Kimura M, Hatori N, Furuki T, Sakai H, Takihata M, Umezono T, Ito S, Suzuki D, Takeda H, Kanamori A, Degawa H, Yamamoto H, Machimura H, Mokubo A, Chin K, Obana M, Hishiki T, Aoyama K, Nakajima S, Umezawa S, Shimura H, Aoyama T, Sato K, Miyakawa M.

Clin Exp Hypertens. 2019;41(7):637-644. doi: 10.1080/10641963.2018.1529778. Epub 2018 Oct 29.

PMID:
30373408
35.

Retrospective analysis of effects of sodium-glucose co-transporter 2 inhibitor in Japanese type 2 diabetes mellitus patients with chronic kidney disease.

Kobayashi K, Toyoda M, Kimura M, Hatori N, Furuki T, Sakai H, Takihata M, Umezono T, Ito S, Suzuki D, Takeda H, Kanamori A, Degawa H, Yamamoto H, Machimura H, Mokubo A, Chin K, Obana M, Hishiki T, Aoyama K, Nakajima S, Umezawa S, Shimura H, Aoyama T, Sato K, Miyakawa M.

Diab Vasc Dis Res. 2019 Jan;16(1):103-107. doi: 10.1177/1479164118802759. Epub 2018 Oct 4.

PMID:
30284913
36.

Novel Therapeutic Approaches to Allosensitization and Antibody-mediated Rejection.

Jordan SC, Ammerman N, Choi J, Huang E, Peng A, Sethi S, Najjar R, Toyoda M, Lim K, Louie S, Vo A.

Transplantation. 2019 Feb;103(2):262-272. doi: 10.1097/TP.0000000000002462. Review.

PMID:
30247320
37.

[Is Balloon-Occluded Transcatheter Arterial Chemoembolization Effective in Patients with Hepatocellular Carcinoma That Is Unresponsive to Conventional Transcatheter Arterial Chemoembolization ?]

Hatanaka T, Arai H, Shibasaki M, Tojima H, Takizawa D, Toyoda M, Takayama H, Abe T, Sato K, Kakizaki S.

Gan To Kagaku Ryoho. 2018 Sep;45(9):1291-1296. Japanese.

PMID:
30237370
38.

Detection of Autonomic Nervous System Abnormalities in Diabetic Patients by 24-hour Ambulatory Blood Pressure Monitoring.

Kimura M, Toyoda M, Ono M, Saito N, Kaneyama N, Miyauchi M, Umezono T, Fukagawa M.

Tokai J Exp Clin Med. 2018 Sep 20;43(3):97-102.

39.

Adipose-derived stem cells enhance human breast cancer growth and cancer stem cell-like properties through adipsin.

Goto H, Shimono Y, Funakoshi Y, Imamura Y, Toyoda M, Kiyota N, Kono S, Takao S, Mukohara T, Minami H.

Oncogene. 2019 Feb;38(6):767-779. doi: 10.1038/s41388-018-0477-8. Epub 2018 Sep 3.

PMID:
30177835
40.
41.

Migration of Deformable Vesicles Induced by Ionic Stimuli.

Kodama A, Morandi M, Ebihara R, Jimbo T, Toyoda M, Sakuma Y, Imai M, Puff N, Angelova MI.

Langmuir. 2018 Sep 25;34(38):11484-11494. doi: 10.1021/acs.langmuir.8b02105. Epub 2018 Sep 12.

PMID:
30156845
42.

Enhancing the effects of exfoliated carbon nanofibers using bone morphogenetic protein in a rat spinal fusion model.

Notani N, Miyazaki M, Toyoda M, Kanezaki S, Ishihara T, Tsumura H.

J Orthop Res. 2018 Nov;36(11):2892-2900. doi: 10.1002/jor.24073. Epub 2018 Jul 23.

PMID:
29917272
43.

Prediction of permeable thin absorbers using the finite-difference time-domain method.

Toyoda M, Motooka J.

J Acoust Soc Am. 2018 May;143(5):2870. doi: 10.1121/1.5037708.

PMID:
29857741
44.

Successful treatment switch from lenvatinib to sorafenib in a patient with radioactive iodine-refractory differentiated thyroid cancer intolerant to lenvatinib due to severe proteinuria.

Goto H, Kiyota N, Otsuki N, Imamura Y, Chayahara N, Suto H, Nagatani Y, Toyoda M, Mukohara T, Nibu KI, Kasahara T, Ito Y, Miya A, Hirokawa M, Miyauchi A, Minami H.

Auris Nasus Larynx. 2018 Dec;45(6):1249-1252. doi: 10.1016/j.anl.2018.05.003. Epub 2018 May 18.

PMID:
29779695
45.

Distribution of erlotinib in rash and normal skin in cancer patients receiving erlotinib visualized by matrix assisted laser desorption/ionization mass spectrometry imaging.

Nishimura M, Hayashi M, Mizutani Y, Takenaka K, Imamura Y, Chayahara N, Toyoda M, Kiyota N, Mukohara T, Aikawa H, Fujiwara Y, Hamada A, Minami H.

Oncotarget. 2018 Apr 6;9(26):18540-18547. doi: 10.18632/oncotarget.24928. eCollection 2018 Apr 6.

46.

3D Culture Represents Apoptosis Induced by Trastuzumab Better than 2D Monolayer Culture.

Tatara T, Mukohara T, Tanaka R, Shimono Y, Funakoshi Y, Imamura Y, Toyoda M, Kiyota N, Hirai M, Kakeji Y, Minami H.

Anticancer Res. 2018 May;38(5):2831-2839.

PMID:
29715106
47.

Improved Quantitative Dynamic Range of Time-of-Flight Mass Spectrometry by Simultaneously Waveform-Averaging and Ion-Counting Data Acquisition.

Kawai Y, Hondo T, Jensen KR, Toyoda M, Terada K.

J Am Soc Mass Spectrom. 2018 Jul;29(7):1403-1407. doi: 10.1007/s13361-018-1967-1. Epub 2018 Apr 26.

PMID:
29700728
48.

Raltegravir-associated Diabetic Ketoacidosis in a Patient with HIV Infection: A Case Report.

Horikawa M, Toyoda M, Saito N, Kimura M, Kobayashi T, Takagi A, Fukagawa M.

Tokai J Exp Clin Med. 2018 Apr 20;43(1):19-23.

49.

Characteristic glycopeptides associated with extreme human longevity identified through plasma glycoproteomics.

Miura Y, Hashii N, Ohta Y, Itakura Y, Tsumoto H, Suzuki J, Takakura D, Abe Y, Arai Y, Toyoda M, Kawasaki N, Hirose N, Endo T.

Biochim Biophys Acta Gen Subj. 2018 Jun;1862(6):1462-1471. doi: 10.1016/j.bbagen.2018.03.025. Epub 2018 Mar 24.

PMID:
29580922
50.

Discovery of a Fungal Multicopper Oxidase That Catalyzes the Regioselective Coupling of a Tricyclic Naphthopyranone To Produce Atropisomers.

Kawaguchi M, Ohshiro T, Toyoda M, Ohte S, Inokoshi J, Fujii I, Tomoda H.

Angew Chem Int Ed Engl. 2018 Apr 23;57(18):5115-5119. doi: 10.1002/anie.201800415. Epub 2018 Mar 22.

PMID:
29468784

Supplemental Content

Loading ...
Support Center